We use cookies for a better user experience. Read our Privacy Policy
I Agree
Gastrointestinal Bleeding Treatment Market
Gastrointestinal bleeding is also known as gastrointestinal hemorrhage. It includes all forms of bleeding of gastrointestinal tract, from the mouth to the rectum. Endoscopic hemostatic devices are the primary line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic devices include thermal and mechanical.
The global gastrointestinal bleeding treatment market is anticipated to expand at a CAGR of 4.5% during the forecast period. Growth of the market can be attributed to rise in demand for endoscopic hemostasis which is considered the first line of treatment for gastrointestinal bleeding, increase in geriatric population, surge in applications of endoscopic hemostasis, significant product launches, strategic acquisitions by key players, and government and non-government funding for research and to spread awareness about gastrointestinal bleeding treatment. However, shortage of trained gastroenterologists, significant product recalls, and limitations of endoscopic treatment are likely to hamper the growth of the global market.
In terms of product, the global gastrointestinal bleeding treatment market has been segmented into endoscopic hemostatic devices, closure devices, and others. The endoscopic hemostatic devices segment has been categorized into mechanical devices and thermal devices. The thermal devices sub-segment dominated the endoscopic hemostatic devices segment in 2017. However, the mechanical devices sub-segment is anticipated to expand at a high CAGR during the forecast period. Growth of the segment can be attributed to increase in usage of these devices for the treatment of upper GI tract bleeding. For instance, band ligation is considered to be the first line of treatment for esophageal varices.
Based on GI tract division, the global gastrointestinal bleeding treatment market has been classified into upper GI tract and lower GI tract. The upper GI tract segment dominated the market in 2017 and the trend is likely to continue during in the forecast period. Growth of the segment can be attributed to increase in the number of hospitalizations owing to upper GI tract bleeding. Upper GI tract bleeding is one of the common emergencies reported and accounts for over 250,000 hospitalizations in the U.S. and over 300,000 hospitalizations in the U.K. each year. Peptic ulcer which is one of the common causes of upper GI tract bleeding is known to have significant prevalence owing to increase in H. pylori infections.
In terms of end-user, the global gastrointestinal bleeding treatment market has been divided into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2017. It is expected to continue to dominate the market during the forecast period. Hospitals are major end-users of endoscopic hemostatic devices. According to government health care facilities, hospitals have reimbursement plans and systems with advanced technology for disease treatment. Growth of the segment is attributed to increase the number of treatments and hospital facilities across the world. According to the American Hospital Association, the total number of registered hospitals in the U.S. stood at nearly 5,686 in 2015.
In terms of region, the global gastrointestinal bleeding treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe accounted for over 75% share of the market in 2018. The two regions are anticipated to continue to dominate the global market in terms of revenue during the forecast period. North America is expected to dominate the global market during the forecast period owing to the presence of leading market players and strategic mergers and partnerships among players. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Growth of the market in the region is attributed to increase in the geriatric population, rise in prevalence of GI bleeding with age, and growing focus of market players on exploiting the untapped markets in India and Japan.
Key companies operating in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.
Intensive Smoking and Drinking Habits leading to Intestinal Diseases to Aid in Expansion of Gastrointestinal Bleeding Treatment Market
Gastrointestinal bleeding is otherwise called gastrointestinal drain. It incorporates all types of bleeding of gastrointestinal parcel, from the mouth to the rectum. Endoscopic hemostatic gadgets are the essential line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic gadgets incorporate warm and mechanical. Development of the market can be credited to ascend sought after for endoscopic hemostasis which is viewed as the primary line of treatment for gastrointestinal bleeding, expansion in geriatric populace, flood in uses of endoscopic hemostasis, critical item dispatches, vital acquisitions by central participants, and government and non-government financing for research and to spread mindfulness about gastrointestinal bleeding treatment. In any case, lack of prepared gastroenterologists, critical item reviews, and restrictions of endoscopic treatment are probably going to hamper the development of the worldwide market.
The fundamental driver of gastrointestinal (GI) bleeding is concentrated smoking and liquor utilization that seriously influences gastric emissions. The adjustment of way of life designs has expanded the quantity of cases with GI bleeding. the rising accomplishment of endoscopy treatments has prompted the interest for endoscopy hemostatic techniques for GI bleeding treatment. It is utilized as a broad instrument to stop dynamic bleeding and forestall rebleeding. The quantity of individuals matured over 65 and experiencing GI bleeding and request from this age bunch is expanding and accordingly driving the market. Expanded financing in medical clinics has brought request up on the lookout. In any case, the excessive cost of endoscopy gadgets may hamper market development.
Ascend in commonness of gastrointestinal bleeding with age, expansion in occurrence of re-bleeding cases, and flood in appropriation of endoscopic hemostasis as the essential line of treatment for gastrointestinal bleeding add to the development of the worldwide market. Higher pace of hospitalization because of upper GI lot bleeding, higher pervasiveness than lower GI lot bleeding, and simplicity of analysis of upper GI plot bleeding add to the development of the portion. Besides, rate of upper gastrointestinal bleeding ascends with age attributable to increment in utilization of non-steroidal calming drugs (NSAIDs) which incite ulcerogenensis in older patients. As per government medical services offices, emergency clinics have repayment plans and frameworks with cutting edge innovation for illness treatment. Development of the section is ascribed to expand the quantity of treatments and emergency clinic offices across the world.
The global gastrointestinal bleeding treatment market has been segmented as follows:
|
Product |
|
|
GI Tract Division |
|
|
End-user |
|
|
Region |
|
The global gastrointestinal bleeding treatment market was worth US$ 575.3 Mn and is projected to reach a value of US$ 849.8 Mn by the end of 2026
Gastrointestinal bleeding treatment market is anticipated to grow at a CAGR of 4.5% during the forecast period
North america accounted for a major share of the global gastrointestinal bleeding treatment market
The quantity of individuals matured over 65 and experiencing GI bleeding and request from this age bunch is expanding and accordingly driving the gastrointestinal bleeding treatment market
Key players in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms Used
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Product Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Increase in geriatric population
5.2.1.2. Government and non-government funding
5.2.1.3. High prevalence of upper gastrointestinal bleeding
5.2.1.4. Rise in applications of endoscopic hemostasis
5.2.1.5. Significant product launches
5.2.1.6. Strategic acquisitions
5.2.2. Restraints
5.2.2.1. Dearth of skilled labor
5.2.2.2. Product recalls
5.2.2.3. Limitations of endoscopic management
5.2.3. Opportunities
5.2.3.1. Increase in adoption of combination therapy
5.2.3.2. Untapped emerging economies
5.3. Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2016?2026
5.4. Global Gastrointestinal Bleeding Treatment Market Outlook
5.5. Key Industry Developments
5.6. Technological Advancements
5.7. Disease Epidemiological Assessment
5.8. Global Incidence of Gastrointestinal Cancers by Region
5.9. Reimbursement Scenario Assessment
5.10. Strategies Adopted by Top 3 Players
5.11. Healthcare Overview
6. Global Gastrointestinal Bleeding Treatment Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product
6.4. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016?2026
6.4.1. Endoscopic Hemostatic Devices
6.4.1.1. Thermal Devices
6.4.1.2. Mechanical Devices
6.4.2. Closure Devices
6.4.3. Others
6.5. Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
7. Global Gastrointestinal Bleeding Treatment Market Analysis, by GI Tract Division
7.1. Introduction
7.2. Key Findings
7.3. Market Value Share Analysis, by GI Tract Division
7.4. Market Value Forecast, by Procedure, 2016–2026
7.4.1. Upper GI Tract Division
7.4.2. Lower GI Tract Division
7.5. Market Attractiveness, by GI Tract Division
8. Global Gastrointestinal Bleeding Treatment Market Analysis, by End-user
8.1. Introduction
8.2. Key Findings
8.3. Market Value Share Analysis, by End-user
8.4. Market Value Forecast, by End-user, 2016–2026
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Others
8.5. Market Attractiveness, by End-user
9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecasts, by Region
9.1. Introduction
9.2. Regional Outlook
9.3. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Region, 2016–2026
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region
10. North America Gastrointestinal Bleeding Treatment Market Analysis
10.1. Key Findings
10.2. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Country, 2016?2026
10.2.1. U.S.
10.2.2. Canada
10.3. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
10.3.1. Endoscopic Hemostatic Devices
10.3.1.1. Thermal Devices
10.3.1.2. Mechanical Devices
10.3.2. Closure Devices
10.3.3. Others
10.4. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
10.4.1. Upper GI Tract
10.4.2. Lower GI Tract
10.5. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. North America Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product
10.6.3. By GI Tract Division
10.6.4. By End-user
11. Europe Gastrointestinal Bleeding Treatment Market Analysis
11.1. Key Findings
11.2. Europe Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
11.3.1. Endoscopic Hemostatic Devices
11.3.1.1. Thermal Devices
11.3.1.2. Mechanical Devices
11.3.2. Closure Devices
11.3.3. Others
11.4. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
11.4.1. Upper GI Tract
11.4.2. Lower GI Tract
11.5. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Europe Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Product
11.6.3. By GI Tract Division
11.6.4. By End-user
12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia
12.2.5. Rest of Asia Pacific
12.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
12.3.1. Endoscopic Hemostatic Devices
12.3.1.1. Thermal Devices
12.3.1.2. Mechanical Devices
12.3.2. Closure Devices
12.3.3. Others
12.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
12.4.1. Upper GI Tract
12.4.2. Lower GI Tract
12.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Asia Pacific Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Product
12.6.3. By GI Tract Division
12.6.4. By End-user
13. Latin America Gastrointestinal Bleeding Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
13.3.1. Endoscopic Hemostatic Devices
13.3.1.1. Thermal Devices
13.3.1.2. Mechanical Devices
13.3.2. Closure Devices
13.3.3. Others
13.4. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
13.4.1. Upper GI Tract
13.4.2. Lower GI Tract
13.5. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Latin America Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Product
13.6.3. By GI Tract Division
13.6.4. By End-user
14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
14.2.1. GCC Countries
14.2.2. Israel
14.2.3. South Africa
14.2.4. Rest of Middle East & Africa
14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
14.3.1. Endoscopic Hemostatic Devices
14.3.1.1. Thermal Devices
14.3.1.2. Mechanical Devices
14.3.2. Closure Devices
14.3.3. Others
14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
14.4.1. Upper GI Tract
14.4.2. Lower GI Tract
14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Middle East & Africa Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Product
14.6.3. By GI Tract Division
14.6.4. By End-user
15. Competitive Landscape
15.1. Competition Matrix
15.2. Gastrointestinal Bleeding Treatment Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Olympus Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Cook Medical
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Ovesco Endoscopy AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Erbe Elektromedizin GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Steris, plc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. US Medical Innovations, LLC
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
List of Tables
Table 01: Causes and their associate factors of Gastrointestinal Bleeding
Table 02: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Male, by Region
Table 03: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Female, by Region
Table 04: CPT Codes- Endoscopic Hemostatic Procedures – Control of Bleeding
Table 05: CPT Codes- Endoscopic Hemostatic Procedures – Ligation
Table 06: CPT Codes- Endoscopic Hemostatic Procedures – Injection
Table 07: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 08: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 09: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 10: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 12: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 13: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 14: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 15: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 17: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 19: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 20: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 21: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 22: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 23: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 24: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 25: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 26: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 28: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 29: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 30: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 31: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 33: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 34: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Table 35: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
Table 36: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Forecast, 2018–2026
Figure 03: Market Value Share, by Product, 2018
Figure 04: Market Value Share, by GI Tract Division, 2018
Figure 05: Market Value Share, by End-user, 2018
Figure 06: Market Value Share, by Region, 2018
Figure 07: Gastrointestinal Bleeding Treatment – Technological Advances
Figure 08 Causes- Upper Gastrointestinal Bleeding
Figure 09: Classification of peptic ulcers
Figure 10: Types of Lower GI Bleeding
Figure 11: Causes- Lower Gastrointestinal Bleeding
Figure 12: Top 3 Players operating in Market Space
Figure 13: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 14: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
Figure 15: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Closure Devices, 2016–2026
Figure 16: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 17: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thermal Devices, 2016–2026
Figure 18: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mechanical Devices, 2016–2026
Figure 19: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 20: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 21: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 22: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Upper GI Tract Division, 2016–2026
Figure 23: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lower GI Tract Division, 2016–2026
Figure 24: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 25: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 26: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
Figure 27: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2016–2026
Figure 28: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2016–2026
Figure 29: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 30: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 31: Gastrointestinal Bleeding Treatment Market: Regional Outlook
Figure 32: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 33: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region, 2017 and 2026
Figure 34: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Region, 2018-2026
Figure 35: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 36: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country, 2018–2026
Figure 37: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country, 2017 and 2026
Figure 38: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 39: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 40: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 41: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 42: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 43: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 44: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 45: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 46: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 48: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 49: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 50: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 51: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 52: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 53: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 54: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 55: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 56: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 57: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 58: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 59: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 60: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 61: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 62: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 63: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 64: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 65: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 66: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 67: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 68: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 69: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 70: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 71: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 72: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 73: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 74: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 75: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 76: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 77: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 78: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
Figure 79: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
Figure 80: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 81: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
Figure 82: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
Figure 83: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
Figure 84: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
Figure 85: Global Gastrointestinal Bleeding Treatment Market Share Ana
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes